You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Collaborative Virtual Combat Simulation Technology For System of Systems Research
SBC: 3D PIPELINE SIMULATION CORP. Topic: AF05210Our proposal is constructed around a mature, government-owned, distributed simulation architecture known as Joint Force Operational Readiness Combat Effectiveness Simulator (JFORCES) and a proven three-step computer-aided methodology known as Rapid Relational Modeling (RRM). The proposal includes definition, structuring and prioritizing of project goals and requirements using consensus of end-use ...
SBIR Phase I 2005 Department of DefenseAir Force -
Development of an Innovative Practical UAV with no Moving Aerodynamic Control Surfaces
SBC: Aerotonomy, Incorporated Topic: AF05246Aerotonomy, Incorporated (AI) and subcontractor Georgia Tech Research Institute (GTRI) will apply the latest knowledge in circulation control and piezo-electric synthetic (zero net mass flux) jet actuators (SJAs) to develop a practical small UAV with no hinged control surfaces. In the area of flow control, low jet momentum coefficient SJAs have been used primarily as a mechanism to keep flow atta ...
SBIR Phase I 2005 Department of DefenseAir Force -
Transdermal Hydromorphone for Acute and Chronic Pain
SBC: Altea Therapeutics Corporation Topic: N/ADESCRIPTION (provided by applicant): Founded in 1998, Altea Therapeutics is developing its PassPort(tm) system to deliver proteins and peptides, small-molecule drugs, genes and vaccines from a skin patch, eliminating the need for invasive needle injection. This breakthrough technology, currently undergoing Phase 1 clinical trials for basal insulin delivery, revolutionizes the way in which medicine ...
SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health -
Non-Invasive Drug Delivery by Thermal Microporation
SBC: Altea Therapeutics Corporation Topic: N/ADESCRIPTION (provided by applicant): Founded in 1998, Altea Therapeutics is developing its PassPort(tm) transdermal drug delivery system to deliver proteins and peptides, small-molecule drugs, genes and vaccines from a skin patch, eliminating the need for invasive needle injection. This breakthrough technology, currently undergoing Phase 1 clinical trials for transdermal delivery of insulin and ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Diagnostic for Age-Related Macular Degeneration
SBC: APELIOTUS TECHNOLOGIES, INC. Topic: N/ADESCRIPTION (provided by applicant): Apeliotus Technologies proposes to develop a commercial diagnostic for the early detection of age-related macular degeneration (ARMD). It relies on a functional test of dark adaptation kinetics (the transition from being light-adapted to being dark-adapted) that has been shown in previous work to detect the onset of ARMD at least four years before it is clinic ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Flavonoid Compounds for the Prevention of Osteoporosis
SBC: Aptotec, Inc. Topic: N/ADESCRIPTION (provided by applicant): Approximately 10 million people in the U.S. are estimated to have osteoporosis, a disease that results in over 1.5 million bone fractures a year. It is now known that the accumulation of fat cells (adipocytes) in bone marrow is a major factor contributing to age-related bone loss. Women with osteoporosis have higher numbers of marrow adipocytes than those wome ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Demonstration of Augmented UAV Flight Performance Using Nonthermal Plasma Actuators
SBC: Atmospheric Glow Technologies Topic: AF04166An effective surface flow controller for the manipulation of the properties of aerodynamic boundary layers, particularly the resulting body drag and airflow attachment, has been long sought after. The goal has always been a surface airflow controller that is able to manipulate the aerodynamic boundary layer while both saving fuel (reducing power consumption) and improving the aircraft performance ...
SBIR Phase II 2005 Department of DefenseAir Force -
New Decontamination for Aircraft Cargo Interior
SBC: Atmospheric Glow Technologies Topic: AF04063Atmospheric Glow Technologies proposes to develop the Plasma Agent Neutralization Elimination (PLANE) System based upon its patented One Atmosphere Uniform Glow Discharge Plasma (OAUGDP) technology. When developed, this advanced design will serve as a system for the decontamination of aircraft and associated cargo. AGT has demonstrated the success of OAUGDP in decontaminating various substrates ...
SBIR Phase II 2005 Department of DefenseAir Force -
Specific Diagnostic for Members of Genus Mycobacterium
SBC: ATOM SCIENCES, INC. Topic: N/ADESCRIPTION (provided by applicant): A novel microarray-based system is proposed for diagnosis of tuberculosis and tuberculosis-like respiratory infections. This diagnostic system offers a parallel method to screen clinical samples for the presence of DNA sequences from Mycobacterium tuberculosis, the causative agent of human tuberculosis, and closely related mycobacterial species, while simultan ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Avian transgenesis via site-directed integration
SBC: AviGenics Inc. Topic: N/ADESCRIPTION (provided by applicant): This Phase II SBIR project describes a novel method to create transgenic poultry that will produce biopharmaceutical proteins in their eggs. Chickens are able to produce large amounts of protein in their eggs at relatively low cost. We seek to harness this capability to synthesize pharmaceutical proteins, such as humanized monoclonal antibodies, that are neede ...
SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health